| Direct binding of human NK cell natural cytotoxicity receptor NKp44 to the surfaces of mycobacteria and other bacteria S Esin, G Batoni, C Counoupas, A Stringaro, FL Brancatisano, M Colone, ... Infection and Immunity 76 (4), 1719-1727, 2008 | 184 | 2008 |
| Interaction of Mycobacterium tuberculosis Cell Wall Components with the Human Natural Killer Cell Receptors NKp44 and Toll‐Like Receptor 2 S Esin, C Counoupas, A Aulicino, FL Brancatisano, G Maisetta, D Bottai, ... Scandinavian journal of immunology 77 (6), 460-469, 2013 | 121 | 2013 |
| A composite fibrin-based scaffold for controlled delivery of bioactive pro-angiogenetic growth factors E Briganti, D Spiller, C Mirtelli, S Kull, C Counoupas, P Losi, S Senesi, ... Journal of Controlled Release 142 (1), 14-21, 2010 | 90 | 2010 |
| Delta inulin-based adjuvants promote the generation of polyfunctional CD4+ T cell responses and protection against Mycobacterium tuberculosis infection C Counoupas, R Pinto, G Nagalingam, WJ Britton, N Petrovsky, ... Scientific reports 7 (1), 8582, 2017 | 61 | 2017 |
| The ESX-5 Associated eccB5-eccC5 Locus Is Essential for Mycobacterium tuberculosis Viability M Di Luca, D Bottai, G Batoni, M Orgeur, A Aulicino, C Counoupas, ... PLoS One 7 (12), e52059, 2012 | 57 | 2012 |
| A single dose, BCG-adjuvanted COVID-19 vaccine provides sterilising immunity against SARS-CoV-2 infection C Counoupas, MD Johansen, AO Stella, DH Nguyen, AL Ferguson, ... npj Vaccines 6 (1), 143, 2021 | 48 | 2021 |
| Mucosal delivery of a multistage subunit vaccine promotes development of lung-resident memory T cells and affords interleukin-17-dependent protection against pulmonary tuberculosis C Counoupas, KC Ferrell, A Ashhurst, ND Bhattacharyya, G Nagalingam, ... npj Vaccines 5 (1), 105, 2020 | 48 | 2020 |
| TBVAC2020: advancing tuberculosis vaccines from discovery to clinical development SHE Kaufmann, HM Dockrell, N Drager, H McShane, O Neyrolles, ... Frontiers in immunology 8, 293460, 2017 | 48 | 2017 |
| The generation of T‐cell memory to protect against tuberculosis C Counoupas, JA Triccas Immunology and Cell Biology 97 (7), 656-663, 2019 | 25 | 2019 |
| Protective efficacy of recombinant BCG over-expressing protective, stage-specific antigens of Mycobacterium tuberculosis C Counoupas, R Pinto, G Nagalingam, WJ Britton, JA Triccas Vaccine 36 (19), 2619-2629, 2018 | 25 | 2018 |
| Deciphering protective immunity against tuberculosis: implications for vaccine development C Counoupas, JA Triccas, WJ Britton Expert Review of Vaccines 18 (4), 353-364, 2019 | 23 | 2019 |
| Mycobacterium tuberculosis components expressed during chronic infection of the lung contribute to long-term control of pulmonary tuberculosis in mice C Counoupas, R Pinto, G Nagalingam, GA Hill-Cawthorne, CG Feng, ... npj Vaccines 1 (1), 1-11, 2016 | 23 | 2016 |
| Novel vaccination approaches to prevent tuberculosis in children JA Triccas, C Counoupas Pneumonia 8, 1-7, 2016 | 18 | 2016 |
| The Ag85B protein of the BCG vaccine facilitates macrophage uptake but is dispensable for protection against aerosol Mycobacterium tuberculosis infection KA Prendergast, C Counoupas, L Leotta, C Eto, W Bitter, N Winter, ... Vaccine 34 (23), 2608-2615, 2016 | 18 | 2016 |
| In vitro evaluation of the PEtU-PDMS material immunocompatibility: the influence of surface topography and PDMS content D Spiller, C Mirtelli, P Losi, E Briganti, S Sbrana, C Counoupas, S Kull, ... Journal of Materials Science: Materials in Medicine 20 (12), 2511-2520, 2009 | 18 | 2009 |
| Mucosal TLR2-activating protein-based vaccination induces potent pulmonary immunity and protection against SARS-CoV-2 in mice AS Ashhurst, MD Johansen, JWC Maxwell, S Stockdale, CL Ashley, ... Nature Communications 13 (1), 6972, 2022 | 11 | 2022 |
| Virulence mechanisms of Mycobacterium abscessus: Current knowledge and implications for vaccine design KC Ferrell, MD Johansen, JA Triccas, C Counoupas Frontiers in Microbiology 13, 842017, 2022 | 11 | 2022 |
| A single dose, BCG-adjuvanted SARS-CoV-2 vaccine induces Th1-polarized immunity and high-titre neutralizing antibodies in mice C Counoupas, AO Stella, ND Bhattacharyya, A Grey, K Patel, ... bioRxiv, 2020.12. 10.419044, 2020 | 11* | 2020 |
| High-titer neutralizing antibodies against the SARS-CoV-2 delta variant induced by alhydroxyquim-ii-adjuvanted trimeric spike antigens C Counoupas, P Pino, AO Stella, C Ashley, H Lukeman, ... Microbiology Spectrum 10 (1), e01695-21, 2022 | 10 | 2022 |
| Intrapulmonary vaccination with delta-inulin adjuvant stimulates non-polarised chemotactic signalling and diverse cellular interaction KC Ferrell, EL Stewart, C Counoupas, TM Ashhurst, WJ Britton, ... Mucosal Immunology 14 (3), 762-773, 2021 | 10 | 2021 |
